Lonza, Northwest End Genetics Patent Wrangle

Law360, New York (April 24, 2008, 12:00 AM EDT) -- Swiss biotechnology firm Lonza Group AG has settled its patent infringement lawsuit against Northwest Biotherapeutics Inc. over gene expression technology.

Bethesda, Md.-based Northwest has agreed to destroy Lonza’s glutamine synthetase gene expression system materials in its possession, Lonza said in a statement Thursday.

In light of the agreement, Judge Roger W. Titus of the U.S. District Court for the District of Maryland dismissed all claims and counterclaims between the parties on April 15. Each party will bear its own costs, the judge said.

Attorneys for both...
To view the full article, register now.